No Additional Tariffs on Indian Pharma and Electronics Exports to the US
The Indian government announced that no new tariffs will be imposed on exports to the US in the pharmaceuticals and electronics sectors. However, a 25% reciprocal tariff is applied on other goods since August 7. India continues trade talks with the US to promote long-term trade stability.
- Country:
- India
In recent developments, the Indian government confirmed that no additional tariffs have been levied on Indian exports to the US, particularly in sectors such as pharmaceuticals and electronics.
Minister of State for Commerce and Industry, Jitin Prasada, informed the Lok Sabha of a 25% reciprocal tariff imposed since August 7 on certain exports to the US. This affects approximately 55% of India's merchandise exports to the US.
Prasada emphasized that robust discussions are ongoing with the US, aiming to expand trade and ensure tariff stability. Notably, negotiations for the India-US bilateral trade agreement have progressed through five rounds, with the sixth round scheduled in India later this month.
- READ MORE ON:
- Tariffs
- Exports
- India
- US
- Pharmaceuticals
- Electronics
- Trade Agreement
- Reciprocal
- Negotiations
- Commerce
Advertisement
ALSO READ
Alembic Pharmaceuticals Secures USFDA Nod for Carbamazepine Tablets
US-EU Trade Agreement: A New Era or Forced Compromise?
Torrent Pharmaceuticals: Riding the Wave of Revenue Growth
U.S. and EU Strike a Landmark Trade Agreement, Averting Bigger Trade War
India-UK Free Trade Agreement: A New Era of Strategic Partnership
Google News